Shimekake Y, Kawabata T, Nakamura M, Nagata K
Shionogi Research Laboratories, Shionogi and Co., Ltd., Osaka, Japan.
FEBS Lett. 1992 Sep 7;309(2):185-9. doi: 10.1016/0014-5793(92)81091-y.
Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) have different C-terminal tail structures compared with the rather conservative ring structures which consist of 17 amino acid residues. To examine the different effects of the tail structures of ANP and BNP on their interaction with receptors, we synthesized several peptide analogs and measured their biological actions in three different assay systems. Deletion of the C-terminal tail from rat BNP did not effect the vasorelaxation activity against rat aorta, but it promoted cGMP production in cultured rat aortic smooth muscle cells (RASMC). Deletion of the C-terminal tail from rat ANP diminished both vasorelaxant and cGMP producing activities. In a binding competition assay with RASMC and [125I]rat ANP-(1-28), the competition activities of both ANP and BNP were greatly reduced by C-terminal deletion. In addition, we obtained agonists with novel receptor selectivity.
与由17个氨基酸残基组成的相对保守的环状结构相比,心房利钠肽(ANP)和脑利钠肽(BNP)具有不同的C末端尾部结构。为了研究ANP和BNP尾部结构对其与受体相互作用的不同影响,我们合成了几种肽类似物,并在三种不同的检测系统中测量了它们的生物学活性。从大鼠BNP中删除C末端尾部对大鼠主动脉的血管舒张活性没有影响,但它促进了培养的大鼠主动脉平滑肌细胞(RASMC)中cGMP的产生。从大鼠ANP中删除C末端尾部会降低血管舒张和cGMP产生活性。在与RASMC和[125I]大鼠ANP-(1-28)的结合竞争试验中,ANP和BNP的竞争活性都因C末端缺失而大大降低。此外,我们获得了具有新型受体选择性的激动剂。